Product Information
GANIRELIX ACET 250 MCG/0.5 ML is a generic product labeled by Fresenius Kabi USA, LLC, priced at $62.3467 per ML under NDC 65219002805. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Feb 28, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 ug/.5mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219002805
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
12/17/2025
Active Ingredients
GANIRELIX ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA215658FDA Approved
2/28/2023
TE Code
AP
On Market Since
3/24/2023
Pharmacological Classes
Price Statistics
The NADAC for GANIRELIX ACET 250 MCG/0.5 ML has been published 111 times since Aug 21, 2024, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $62.3467 per ML |
|---|---|
| All-time high | $100.4200 (Sep 11, 2024) |
| All-time low | $62.3467 (Dec 17, 2025) |
| 52-week high | $72.9180 |
| 52-week low | $62.3467 |
| Median price | $75.3895 |
| Average price | $77.4073 |
| Largest weekly change | -10.2% (Aug 20, 2025) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ganirelix Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Gonadotropin Releasing Hormone Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GANIRELIX ACET 250 MCG/0.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for GANIRELIX ACET 250 MCG/0.5 ML, manufactured by Fresenius Kabi USA, LLC, is $62.3467 per ML (NDC 65219002805), effective Sep 30, 2026.
How has the price of GANIRELIX ACET 250 MCG/0.5 ML changed over time?
Over the history we have for it, the NADAC for GANIRELIX ACET 250 MCG/0.5 ML has declined 37.9%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for GANIRELIX ACET 250 MCG/0.5 ML?
Since Aug 21, 2024, the NADAC for GANIRELIX ACET 250 MCG/0.5 ML has ranged from a low of $62.3467 (Dec 17, 2025) to a high of $100.4200 (Sep 11, 2024), with a median of $75.3895 per ML.
Are there cheaper alternatives to GANIRELIX ACET 250 MCG/0.5 ML?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GANIRELIX ACET 250 MCG/0.5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures GANIRELIX ACET 250 MCG/0.5 ML?
GANIRELIX ACET 250 MCG/0.5 ML (NDC 65219002805) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.